AUXLY TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 15, 2024 - StockTitan
| XLY Stock | CAD 0.03 0.01 14.29% |
About 61% of Auxly Cannabis' investor base is looking to short. The analysis of overall sentiment of trading Auxly Cannabis Group stock suggests that many investors are alarmed at this time. Auxly Cannabis' investing sentiment overview a quick insight into current market opportunities from investing in Auxly Cannabis Group. Many technical investors use Auxly Cannabis Group stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Auxly |
AUXLY TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 15, 2024 StockTitan
Read at news.google.com
 |
Auxly Cannabis Fundamental Analysis
We analyze Auxly Cannabis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Auxly Cannabis is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Auxly Cannabis Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Auxly Cannabis stock to make a market-neutral strategy. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics with similar companies.
Peers
Auxly Cannabis Related Equities
| XEG | IShares SPTSX | 2.07 | ||||
| ALA-PA | Altagas Cum | 1.35 | ||||
| ERE-UN | European Residential | 0.53 | ||||
| RUDB | RBC Discount | 0.05 | ||||
| XHB | IShares Canadian | 0.20 | ||||
| LOVE | Cannara Biotech | 4.00 |
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.